Cabaletta Bio is trading 10.33% lower at $1.52, with broad-market pressure providing context; no clear company-specific catalyst has been identified. - September CPI rose 3.7% year over year, above the 3.6% forecast, renewing concerns about Federal Reserve rate policy. - The broader market is sharply lower, and the biotech sector is down 2.01%. - Shares closed lower in each of the prior four sessions. No volume information was provided.